Suzaki_2013_Eur.J.Clin.Pharmacol_69_21

Reference

Title : The effect of carboxylesterase 1 (CES1) polymorphisms on the pharmacokinetics of oseltamivir in humans - Suzaki_2013_Eur.J.Clin.Pharmacol_69_21
Author(s) : Suzaki Y , Uemura N , Takada M , Ohyama T , Itohda A , Morimoto T , Imai H , Hamasaki H , Inano A , Hosokawa M , Tateishi M , Ohashi K
Ref : European Journal of Clinical Pharmacology , 69 :21 , 2013
Abstract : Suzaki_2013_Eur.J.Clin.Pharmacol_69_21
ESTHER : Suzaki_2013_Eur.J.Clin.Pharmacol_69_21
PubMedSearch : Suzaki_2013_Eur.J.Clin.Pharmacol_69_21
PubMedID: 22673926

Related information

Citations formats

Suzaki Y, Uemura N, Takada M, Ohyama T, Itohda A, Morimoto T, Imai H, Hamasaki H, Inano A, Hosokawa M, Tateishi M, Ohashi K (2013)
The effect of carboxylesterase 1 (CES1) polymorphisms on the pharmacokinetics of oseltamivir in humans
European Journal of Clinical Pharmacology 69 :21

Suzaki Y, Uemura N, Takada M, Ohyama T, Itohda A, Morimoto T, Imai H, Hamasaki H, Inano A, Hosokawa M, Tateishi M, Ohashi K (2013)
European Journal of Clinical Pharmacology 69 :21